Silicone Oil Emulsification after Vitrectomy for Rhegmatogenous Retinal Detachment
Table 4
Comparison of clinical factors and characteristics of emulsified silicone oil droplets between patients using or not using antiglaucoma medications after silicone oil removal.
Variable
Use of antiglaucoma medications
Yes
No
Patients
8
30
Age (years)
54 ± 15
56 ± 9
0.792
AL (mm)
25.36 ± 2.79
26.18 ± 2.540
0.492
IOP (mmHg)
21.1 ± 5.1
17.4 ± 5.1
0.028
Duration of SO in situ (days)
163 ± 44
199 ± 106
0.297
Time course of vitrectomy (min)
70 ± 16
70 ± 16
1.000
Total number of droplets
0.84 × 106 ± 0.54 × 106
2.26 × 106 ± 4.40 × 106
0.586
Droplets in different diameter
1-<2 μm
0.65 × 106 ± 0.43 × 106
2.06 × 106 ± 4.35 × 106
0.515
2-<3 μm
1.02 × 105 ± 0.72 × 105
1.00 × 105 ± 0.63 × 105
1.000
3-<4 μm
4.17 × 104 ± 3.58 × 104
4.92 × 104 ± 9.15 × 104
0.847
4-<5 μm
1.79 × 104 ± 1.44 × 104
4.06 × 104 ± 8.94 × 104
0.739
5–<7 μm
2.18 × 104 ± 2.14 × 104
1.00 × 104 ± 1.45 × 104
0.041
7–<12 μm
0.95 × 104 ± 0.64 × 104
0.40 × 104 ± 0.54 × 104
0.012
Values are expressed as mean ± standard deviation. was considered statistically significant. AL, axial length; IOP, intraocular pressure; SO, silicone oil; PPV, pars plana vitrectomy.